BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Edison Pharmaceuticals, Inc. 

5941 Optical Court, Suite 228

San Jose  California  95138  U.S.A.
Phone: 408-960-2910 Fax: 408-413-5300


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





 Company News
FDA Grants Fast Track Status To Edison Pharmaceuticals, Inc.' EPI-743 For Friedreich's Ataxia 3/17/2014 9:48:00 AM    More...
Edison Pharmaceuticals, Inc. Announces Initiation Of EPI-743 Pearson Syndrome Clinical Trial 3/17/2014 8:13:35 AM    More...
Edison Pharmaceuticals, Inc. Announces Initiation Of EPI-743 Phase 2B/3 Leigh Syndrome Clinical Trial With Dainippon Sumitomo Pharma Co., Ltd. In Japan 3/10/2014 12:29:22 PM    More...
FDA Grants Edison Pharmaceuticals, Inc.'s EPI-743 Orphan Status For Friedreich's Ataxia 2/4/2014 9:54:46 AM    More...
Edison Pharmaceuticals, Inc., Dainippon Sumitomo Pharma Co., Ltd. Ink "Biological Energy" Pact Worth $4.3 Billion 1/31/2014 6:48:05 AM    More...
Edison Pharmaceuticals, Inc., FARA, and University of South Florida Announce Initiation of EPI-743 Phase 2 Friedreich's Ataxia Clinical Trial in Adults with Point Mutations 11/4/2013 9:20:12 AM    More...
Edison Pharmaceuticals, Inc. Announces Initiation of National Institutes of Health (NIH)-Sponsored EPI-743 Clinical Trial With NIH Undiagnosed Diseases Program Patients 9/24/2013 10:52:03 AM    More...
Edison Pharmaceuticals, Inc. Signs Licensing Agreement With Dainippon Sumitomo Pharma Co., Ltd. for Up to $545 Million 3/28/2013 7:35:41 AM    More...
Edison Pharmaceuticals, Inc. & Bambino Gesu Children's Hospital Announce Initiation of EPI-743 Phase 2 Cobalamin C Deficiency Syndrome Clinical Trial 2/19/2013 9:45:54 AM    More...
Edison Pharmaceuticals, Inc. Announces Initiation of EPI-743 Phase 2B Friedreich's Ataxia Clinical Trial 1/7/2013 9:55:22 AM    More...
123

//-->